Details of the Drug | DrugMAP

General Information of Drug (ID: DMQZ3T4)

Drug Name

RX-10001

Indication

Disease Entry	ICD 11	Status	REF
Asthma	CA23	Phase 1	[1]
Rheumatoid arthritis	FA20	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C20H30O5
Canonical SMILES: CCC(C=CC=CCC(C=CC=CC=CC(CCCC(=O)O)O)O)O
InChI: 1S/C20H30O5/c1-2-17(21)11-8-5-9-14-18(22)12-6-3-4-7-13-19(23)15-10-16-20(24)25/h3-9,11-13,17-19,21-23H,2,10,14-16H2,1H3,(H,24,25)/b4-3+,9-5-,11-8+,12-6+,13-7-/t17-,18+,19-/m1/s1
InChIKey: AOPOCGPBAIARAV-OTBJXLELSA-N

Cross-matching ID

PubChem CID: 10473088
ChEBI ID: CHEBI:81559
CAS Number: 552830-51-0
TTD ID: D05ECQ

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030399)